Mallinckrodt Supports New Research Award in Sarcoidosis

A new ATS Foundation/Mallinckrodt Pharmaceuticals Research Fellowship in Sarcoidosis will award $40,000 per year for two years to one investigator conducting research in the area of sarcoidosis.

“Mallinckrodt is proud to support the ATS Foundation in its commitment to research. We are pleased to help establish this fellowship for research in sarcoidosis that can help uncover new insights for healthcare providers and for patients living with this rare disease,” said Tunde Otulana, MD, Senior Vice President and Chief Medical Officer of Mallinckrodt. “It is our hope that these types of collaborations will play an important role in helping to advance pulmonary health science.”

Sarcoidosis is an inflammatory disorder involving multiple organs, and the causes and pathogenesis are unknown.

“As a disease that affects every organ in the body, sarcoidosis is a difficult disease to study. This grant, a partnership between the ATS and Mallinckrodt, will provide critical resources to investigators working to improve the lives of our patients,” said Eric White, MD, director of Translational Interstitial Lung Disease Research, Division of Pulmonary and Critical Care Medicine University of Michigan Medical School. “I have no doubt that recipients of this award will be able to advance the science and move us ever closer to understanding how and why sarcoidosis affects people, and how to best care for sarcoidosis patients.”